Learn how to apply a mindful eating approach and motivational interviewing to your counseling sessions
The dual mechanism also appears to provide better preservation of lean mass during weight loss, though head-to-head comparison data is still limited
Both represent important advances in obesity medicine, and the most appropriate option depends on an individual's medical history , treatment goals , and a discussion with their healthcare provider
It is a triple-hormone receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon (GCG) receptors
#GlobalHealth #BiotechInnovation #ObesityCrisis To view or add a comment, sign in More Relevant Posts WHY NASAL DELIVERY OF GLP-1 PEPTIDES? In contrast to the oral and subcutaneous routes of administration, nasal delivery of GLP-1 peptide drugs provides unique advantages: The nasal mucosal environment is less acidic, less digestive, and simpler to use than the oral delivery route
At least this is what we have seen both in a trial we've conducted ourselves years back with MAR709, our dual-agonist, but also so far in the trial in Phase II and the escalation trials that our colleagues at Eli Lilly have done
